Copyright
©The Author(s) 2017.
World J Gastroenterol. May 14, 2017; 23(18): 3195-3204
Published online May 14, 2017. doi: 10.3748/wjg.v23.i18.3195
Published online May 14, 2017. doi: 10.3748/wjg.v23.i18.3195
Table 2 Preoperative stadiation for patients with hepatocellular carcinoma evaluated for liver transplantation
Diagnostic test | Indications | Comments |
Computed tomography (CT) with contrast medium of chest-abdomen-pelvis | Standard test to perform the diagnosis of hepatocellular carcinoma (HCC) in cirrhotic livers to characterize number, size and location of nodules, and exclude macrovascular invasion and extrahepatic spread | Require adherence to established protocols for optimization |
Magnetic resonance imaging (MRI) with contrast medium of abdomen | Slightly superior to CT according to recent data | Consider in individual patients |
Bone scan | Standard test to exclude bone spread | Cost-effectivity debated |
Alpha-fetoprotein (AFP) | Center-specific cut-off for inclusion on the list and drop-out | Surrogate marker of biological aggressiveness |
Preoperative biopsy | Proposed to assess tumor grading | Low accuracy |
Positron emission tomography (PET) | Proposed predictor of HCC recurrence | Cost-effectivity unclear |
- Citation: Biolato M, Marrone G, Miele L, Gasbarrini A, Grieco A. Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach. World J Gastroenterol 2017; 23(18): 3195-3204
- URL: https://www.wjgnet.com/1007-9327/full/v23/i18/3195.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i18.3195